The epidermal growth factor receptor (EGFR) and Notch signaling pathways have antagonistic roles during epidermal differentiation and carcinogenesis. The molecular mechanisms regulating the crosstalk between EGFR and Notch during epidermal transformation are largely unknown. We found enhanced EGFR-dependent signaling, proliferation and oncogenic transformation caused by loss of presenilins (PS), the catalytic components of csecretase that generates the Notch1 intracellular domain (NICD). The underlying mechanism for abnormal EGFR signaling in PS-deficient cells involves c-secretase-independent transcriptional upregulation of the E3 ubiquitin ligase Fbw7. Fbw7a, which targets NICD for degradation, regulates positively EGFR by affecting a proteasomedependent ubiquitination step essential for constitutive degradation and stability of EGFR. To investigate the pathological relevance of this findings in vivo, we generated a novel epidermal conditional PS-deficient (ePS cDKO) mouse by deleting both PS in keratinocytes of the basal layer of the epidermis. The ePS cDKO mice develop epidermal hyperplasia associated with enhanced expression of both EGFR and Fbw7 and reduced NICD levels in keratinocytes. These findings establish a novel role for PS on epidermal growth and transformation by reciprocally regulating the EGFR and Notch signaling pathways through Fbw7.
The epidermal growth factor receptor (EGFR) and Notch signaling pathways have antagonistic roles during epidermal differentiation and carcinogenesis. The molecular mechanisms regulating the crosstalk between EGFR and Notch during epidermal transformation are largely unknown. We found enhanced EGFR-dependent signaling, proliferation and oncogenic transformation caused by loss of presenilins (PS), the catalytic components of csecretase that generates the Notch1 intracellular domain (NICD). The underlying mechanism for abnormal EGFR signaling in PS-deficient cells involves c-secretase-independent transcriptional upregulation of the E3 ubiquitin ligase Fbw7. Fbw7a, which targets NICD for degradation, regulates positively EGFR by affecting a proteasomedependent ubiquitination step essential for constitutive degradation and stability of EGFR. To investigate the pathological relevance of this findings in vivo, we generated a novel epidermal conditional PS-deficient (ePS cDKO) mouse by deleting both PS in keratinocytes of the basal layer of the epidermis. The ePS cDKO mice develop epidermal hyperplasia associated with enhanced expression of both EGFR and Fbw7 and reduced NICD levels in keratinocytes. These findings establish a novel role for PS on epidermal growth and transformation by reciprocally regulating the EGFR and Notch signaling pathways through Fbw7.
Introduction
Presenilins (PS: PS1 and PS2) are the catalytic components of g-secretase, an enzymatic complex that cleaves type-I transmembrane proteins implicated in cell adhesion, differentiation, survival and proliferation (Koo and Kopan, 2004) . PS/g-secretase-mediated cleavage of the b-amyloid precursor protein has a critical role in Alzheimer's disease pathogenesis presumably by affecting the generation of b-amyloid (De Strooper, 2007) . PS/g-secretase mediates Notch1 activation by releasing the Notch1 intracellular domain (NICD) (De Strooper et al., 1999) . Notch signaling inhibits keratinocyte proliferation by promoting differentiation (Lefort and Dotto, 2004) . Recent findings suggest a role of loss of PS function in epidermal homeostasis. Deletion of both PS during embryogenesis induces abnormal epidermal differentiation and degeneration of hair follicles (Pan et al., 2004; Demehri et al., 2008) , whereas partial loss of PS function in adulthood causes skin hyperplasia and autoimmune disease (Xia et al., 2001; Tournoy et al., 2004) . The tumorigenic phenotype caused by loss of PS1 function seems to be independent of g-secretase activity but associated with enhanced b-catenin signaling (Xia et al., 2001; Kang et al., 2002) . Surprisingly, disruption of PS1/b-catenin interaction by deleting the PS1 loop domain, a region dispensable for g-secretase activity that includes the b-catenin binding domain (Saura et al., 2000) , is not sufficient to induce skin tumors (Deng et al., 2006) . Its noteworthy that two PS2 mutations found in breast tumors increase cell proliferation and reduce Notch signaling indicating that they act through a lossof-function mechanism . This suggests that alternative signaling pathways may be involved in the oncogenic phenotype caused by PS deficiency.
The epidermal growth factor receptor (EGFR) promotes proliferation of keratinocyte-derived epithelial tumors (Kalyankrishna and Grandis, 2006) . EGFR maintains keratinocyte self-renewal in the basal layer of the epidermis by suppressing differentiation and promoting proliferation (Jost et al., 2000) . Notably, although enhanced EGFR signaling contributes to epidermal growth and malignant transformation, Notch signaling suppresses keratinocyte proliferation (Nicolas et al., 2003) . Indeed, EGFR signaling acts as a negative regulator of Notch1 transcription during suppression of keratinocyte differentiation (Kolev et al., 2008) . Reduced PS1 and cleaved Notch1 and elevated EGFR levels were detected in skin papillomas of activating transcription factor-2 knockout mice (Bhoumik et al., 2008) , indicating a possible mechanistic link between Notch and EGFR signaling through PS during epidermal transformation. Moreover, elevated EGFR was recently found in skin tumors of PS1-and nicastrindeficient mice (Li et al., 2007; Zhang et al., 2007) . Two alternative mechanisms of EGFR regulation by PS, one involving repressed EGFR transcription by the g-secretase-derived b-amyloid precursor protein intracellular domain and the other implicating altered EGFR lysosomal targeting, have been postulated (Repetto et al., 2007; Zhang et al., 2007) . Despite the evidence linking PS and EGFR, it is unclear whether PS regulates cell growth and oncogenic transformation through EGFR signaling.
Fbw7, the recognition component of the Skp1-Cul1-F-box protein E3 ubiquitin ligase, acts as a tumor suppressor gene by regulating the ubiquitination and degradation of several regulators of cell division, including Notch1/4, c-Jun, cyclin E, c-Myc and mTOR (Welcker and Clurman, 2008) . The Fbw7 homolog in Caenorhabditis elegans, sel-10/Cdc4, was shown to interact functionally with the PS homolog sel-12 (Wu et al., 1998) , although the physiological function of Fbw7/PS interaction in mammals remains unknown. We examined the hypothesis that PS could inversely regulate EGFR and Notch signaling by affecting Fbw7. Our studies using fibroblasts and primary keratinocytes from PS-deficient mice revealed that PS negatively regulate Fbw7, which enhances EGFR expression and signaling but decreases NICD levels. These results suggest a PS-dependent crosstalk between EGFR and Notch signaling through Fbw7 during cell growth and transformation.
Results

Abnormal cell proliferation and transformation in PS-deficient cells depend on EGFR signaling
Recent evidences indicate that PS negatively regulate EGFR (Repetto et al., 2007; Zhang et al., 2007) , although the relevance of this finding on epidermal tumorigenesis is still unclear. To investigate this issue, we analyzed cell growth and oncogenic transformation in immortalized skin fibroblasts from control (PS1/PS2) and PS double knockout (PSÀ/À) mice. Control and PSÀ/À fibroblasts grew similarly in standard culture conditions (10% fetal bovine serum). By contrast, PSÀ/À fibroblasts grew very rapidly in low and very low serum conditions (0.1-1% fetal bovine serum), suggesting that loss of PS increases the sensitivity of cells to growth factors (Figure 1a ). Stable expression of hPS1 reduced the abnormal proliferation rate of PSÀ/À fibroblasts arguing against side effects of the transformed cell lines (Figure 1a) . In order to discern the specific growth factor receptor(s) involved in the proliferative phenotype, we next performed a pharmacological drug screening. Inhibition of EGFR with PD168393 and PD153035, but not inhibiting ErbB2 (AG825), PDGFR/VEGFR (SU4312), IGFR (picropodophyllin) or FGFR (SU5402), at concentrations that lower ERK1/2 signaling (X10 Â IC 50 ; not shown), significantly decreased the number and density of PSÀ/À fibroblasts (Figure 1b) . Analysis of anchorageindependent growth in soft agar, an assay used previously to study EGFR-dependent oncogenic phenotypes (Di Fiore et al., 1987) , revealed larger and higher number of colonies formed by PSÀ/À fibroblasts compared with control, PS1À/À and PS2À/À fibroblasts, a phenotype that was suppressed by inhibiting EGFR signaling ( Figure 1c and data not shown). These results indicate that abnormal proliferation and transformation caused by loss of PS were dependent on EGFR signaling.
Epidermal hyperplasia and enhanced EGFR signaling in epidermal conditional PS knockout mice To investigate the role of EGFR signaling on epidermal proliferation and transformation caused by loss of PS function in adulthood while avoiding possible epidermal developmental effects (Shen et al., 1997; Pan et al., 2004) , we generated an inducible epidermal conditional PS-deficient mouse (ePS cDKO). Mice carrying PS1 alleles flanked by loxP sites (PS1 f/f) in a PS2À/À background (Saura et al., 2004) were mated to K14-Cre-ER T2 mice expressing the tamoxifen-dependent Cre-ER T2 recombinase, under the control of the human keratin 14 (K14) promoter (Indra et al., 1999; Li et al., 2000) , to generate mice bearing two PS1 floxed (f) and PS2 null alleles and expressing Cre-ER T2 in basal keratinocytes of the epidermis. Tamoxifen administration to such mice induced efficient PS1 ablation selectively in epidermal keratinocytes, thus generating mice lacking PS1 and PS2 in epidermis (Supplementary Figure S1 ). Mutant mice were viable, fertile and they did not exhibit phenotypic abnormalities until 2.5-3 months of age. At this age, ePS cDKO mice showed multiple skin lesions including epidermal hyperplasia and epidermal layer disorganization (Figure 2a) . Interestingly, we found histological features of squamous cell carcinomas, including epidermal hyperplasia, hyperkeratosis, invasive growth pattern and mitotic cells, in the neck skin of ePS cDKO mice (Figure 2b ). Immunohistochemical and biochemical analyses revealed upregulation of EGFR (B2-fold) coinciding with deletion of both PS in skin and primary keratinocytes from ePS cDKO mice (Figures 2a and c) . As K14 promoter is specifically active in basal proliferating keratinocytes (Vasioukhin et al., 1999) , PS1 was detected in some cells of the suprabasal epidermal layer in ePS cDKO mice. (Figures 2c and  d) . These results suggested that epidermal proliferation and transformation caused by loss of PS were associated with increased EGFR levels and signaling.
Presenilins regulate ubiquitination-dependent EGFR degradation We next studied the mechanisms involved in PS/gsecretase-dependent regulation of EGFR signaling by focusing on EGFR transcription and degradation. Inhibition of g-secretase with N-[N-(3,5-difluorophenacetyl-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) resulted in a time-dependent accumulation of b-amyloid precursor protein C-terminal fragments similar to PSÀ/À fibroblasts, whereas EGFR was essentially unchanged (Figure 3a) . Analysis of EGFR mRNA levels by quantitative real-time reverse transcription-PCR showed unchanged EGFR transcripts in PSÀ/À cells (PS1/PS2: 1±0.2-fold vs PSÀ/À: 1±0.1-fold; n ¼ 4-5), whereas activation of EGFR promoter was similar in control (9.3 ± 0.5 U) and PSÀ/À (7.2 ± 0.7 U) fibroblasts (P40.05). These results suggest that regulation of EGFR expression is largely independent of g-secretasedependent transcription. Experiments performed with the protein synthesis inhibitor cycloheximide showed that the half-life of EGFR was significantly increased in the absence (control: B16 h vs PSÀ/À: B48 h) or presence (control: B1 h vs PSÀ/À B3 h) of ligand in PSÀ/À fibroblasts (Figures 3b and c) (Stoscheck and Carpenter, 1984) . Consistent with a role of the lysosomal pathway on EGFR degradation, NH 4 Cl inhibited the degradation of EGFR in unstimulated or stimulated control and PSÀ/À fibroblasts, whereas the proteasome inhibitor lactacystin blocked efficiently EGFR degradation only in control fibroblasts ( Figure 3c ; data not shown). Under these conditions lactacystin inhibited the proteasome-dependent degradation of b-catenin (data not shown). These results indicate that efficient degradation of EGFR depends on proteasome function (Longva et al., 2002) and EGFR degradation was independent of the proteasome in the absence of PS.
EGFR ubiquitination is not required for internalization (Huang et al., 2007) but ubiquitination and proteasome-dependent deubiquitination are required for efficient lysosomal sorting and degradation of EGFR (Longva et al., 2002; Alwan et al., 2003; Huang et al., 2006) . We then tested the hypothesis that PS could regulate EGFR stability by affecting its ubiquitination and/or internalization. In control fibroblasts, low levels of ubiquitinated EGFR were detected in the absence of ligand, whereas EGF treatment increased ubiquitinated The number of colonies present on three plates was quantified after 15 days. This experiment is representative of three independent experiments. Data are presented as mean ± s.e.m of three dishes. *Po0.05, **Po0.001.
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V Rocher-Ros et al EGFR levels (Figures 3d and e) . Interestingly, ubiquitination of EGFR in PSÀ/À fibroblasts was significantly increased (B2-fold) in the absence of ligand (Figure 3d ), whereas EGF induced deubiquitination of multiubiquitinated EGFR species (Mosesson et al., 2003) ( Figure 3e ). Indeed, sustained ubiquitination of EGFR, but not multiubiquitination, coincided with increased phosphorylation and stability of EGFR ( Figure 3e ). The EGFR is cycled through stages of ubiquitination and internalization into early endosomes, and either recycled back to the cell surface or directed to lysosomes for degradation (Marmor and Yarden, 2004) . Time course analysis of cell surface EGFR by biotinylation or EGFAlexa488 labeling revealed unchanged EGFR internalization rate during 15-60 min of ligand treatment in the absence of PS, whereas impaired EGFR recycling and higher accumulation of intracellular EGFR were evident in PSÀ/À fibroblasts at 60-180 min (Supplementary Figure S2 ). Thus, loss of PS stabilizes EGFR by affecting a proteasomal-dependent ubiquitination/ deubiquitination step essential for efficient EGFR trafficking and degradation.
Presenilins negatively regulate the expression and activity of Fbw7
The C. elegans PS homolog sel-12 was previously shown to interact with the ubiquitin ligase sel-10/Cdc4/Fbw7 (Wu et al., 1998) , although the biological function of this interaction remains unknown. We reasoned that PS could regulate EGFR ubiquitination and stability by affecting Fbw7 levels and/or activity. Consistent with this idea, we found a marked increase of Fbw7 coinciding with reduced levels and increased ubiquitination/total protein ratio of its targets c-jun and C-terminal Notch4 in PSÀ/À fibroblasts ( Figure 4a ) (Mao et al., 2004) . Fbw7 staining was observed in perinuclear and nuclear compartments of control fibroblasts. 
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Colocalization imaging analyses revealed that EGFR highly colocalizes with Fbw7 in perinuclear compartments of control fibroblasts (76 ± 13% of Fbw7/EGFR colocalization, n ¼ 40-50 cells). By contrast, we found an increase in Fbw7, especially in the nucleus of PSÀ/À fibroblasts, that highly colocalized with cytosolic and nuclear endogenous EGFR (Fbw7/EGFR colocalization: cytosol, 42±15%, nucleus, 52±24%). As Fbw7 activity depends on its dimerization (Welcker and Clurman, 2007) , we examined the formation of Fbw7 dimers in the presence or absence of PS. Coexpression of Fbw7-Flag and Fbw7-HA plasmids resulted in higher steady-state levels of Fbw7 monomers and dimers in PSÀ/À fibroblasts (Figure 4c ). Inhibition of g-secretase with N-[N-(3,5-difluorophenacetyl-L-alanyl]-S-phenylglycine t-butyl ester did not affect Fbw7 levels, although N-cadherin C-terminal fragments accumulated in a time-dependent manner (Figure 4d ). Consistent with PS-dependent regulation of Fbw7 transcription, we found a significant increase in Fbw7 mRNA transcripts in PSÀ/À fibroblasts (PS1/PS2: 1.0±0.1 vs PSÀ/À: 2.1±0.4-fold; Po0.05) (Figure 4e ). These results showed that PS negatively modulates Fbw7 expression and activity by regulating its transcription.
Fbw7 positively regulates EGFR stability and signaling
The previous results indicated that loss of PS positively regulates Fbw7 expression, which in turn could stabilize EGFR. Indeed, elevated Fbw7 was associated with higher EGFR levels in PSÀ/À fibroblasts, whereas stable expression of PS1, but not a PS1Dloop mutant that lacks the b-catenin binding domain (Saura et al., 2000) , significantly decreased Fbw7 and EGFR levels ( Figure 5a ). This is an interesting finding because the PS1Dloop mutant maintains high cytosolic b-catenin levels (b-catenin/GAPDH: PS1/PS2: 1±0.1, PSÀ/À: 2 ± 0.1, PSÀ/À;PS1: 1.3 ± 0.1, PSÀ/À;PS1DLoop: Fbw7-dependent regulation of EGFR signaling V Rocher-Ros et al 1.8±0.2; n ¼ 4) (Figure 5a ). Isoform-specific degradation of substrates by Fbw7 has been recently reported (Grim et al., 2008) . Consistent with isoform-and E3 ubiquitin ligase-dependent EGFR regulation by Fbw7, Fbw7a but not Fbw7b or the loss of function mutants lacking the F-box domain (Fbw7a/b DF) (Welcker et al., 2004) , stabilized EGFR levels and signaling in 293T cells (Figures 5b and c) . In support of a role of Fbw7 in EGF stabilization, genetic inactivation of Fbw7 by using Fbw7 small interfering RNA or Cre recombinasemediated recombination (Mao et al., 2004) significantly decreased the levels of EGFR in epithelial cells and embryonic fibroblasts (Figure 5d ). Overexpression of Fbw7a in 293T cells enhanced EGFR ubiquitination and caused a rapid deubiquitination of the multiubiquitinated species similar to that found in PSÀ/À cells (Figure 5e ). Together, these results indicate that Fbw7a acts as a positive regulator of EGFR stability and signaling.
Inactivation of PS enhances EGFR-dependent signaling and cell transformation by upregulating Fbw7
To assess whether the above findings apply in conditions of epidermal transformation, we analyzed Fbw7 expression in the epidermis of ePS cDKO mice. Immunohistochemical analyses of skin sections revealed a substantial increase in Fbw7, especially in the nucleus of epidermal cells in ePS cDKO mice (Figure 6a ). We detected upregulation of Fbw7 associated with enhanced EGFR and decreased NICD levels in tamoxifen-treated primary keratinocytes of ePS cDKO mice (Figures 2c  and 6b ). To test the possibility that loss of PS could enhance epidermal proliferation by increasing EGFR signaling through Fbw7, we inactivated Fbw7 by using Fbw7 small interfering RNAs (Mao et al., 2004) . Compared with PSÀ/À fibroblasts (1.5 ± 0.2), stable expression of Fbw7 small interfering RNA reduced the level of Fbw7 mRNAs by 50% (1.10 ± 0.04), which were similar to vector-transfected control fibroblasts (1.00±0.05). Consistent with a role of PS in regulating EGFR stability through Fbw7, Fbw7 silencing in PSÀ/À fibroblasts diminished EGFR while increased c-jun and C-terminal Notch4 and decreased the turnover rate of NICD (Figures 7a and b) . Moreover, Fbw7 inactivation decreased significantly EGFR expression and stability as well as ERK1/2 signaling induced by EGF in PSÀ/À fibroblasts ( Figure 7c) . Finally, the number of PSÀ/À colonies formed in soft-agar was significantly reduced by silencing Fbw7, which was similar to those obtained by inhibiting EGFR (Figure 7d ). These results support the idea that elevated Fbw7 caused by PS inactivation results in EGFR-mediated epidermal transformation.
Discussion
This study provides biochemical evidence that PS inversely modulate the EGFR and Notch pathways by regulating the ubiquitin ligase Fbw7-dependent regulation of EGFR signaling V Rocher-Ros et al between PS (sel-12) and Fbw7 (sel-10/Cdc4) were initially reported in C. elegans, in which loss of sel-10 activity leads to suppression of the egg-laying defective phenotype caused by sel-12 mutants (Wu et al., 1998) . In mammalian cells, Fbw7 regulates PS levels and activity (Li et al., 2002) , but a reciprocal effect has not been investigated. Our results show that PS act as negative regulators of Fbw7. Loss of PS function in fibroblasts and primary keratinocytes results in elevated expression of Fbw7 and decreased Fbw7 targets, including c-jun and Notch1/4. PS-dependent regulation of Fbw7 and EGFR is independent of its proteolytic activity as inhibition of g-secretase does not affect expression of Fbw7 and EGFR. This result agrees with a recent report showing g-secretase-independent regulation of EGFR degradation (Repetto et al., 2007) . Notably, we found that loss of PS enhances Fbw7 mRNA transcripts suggesting that PS negatively modulates Fbw7 transcription. As the PS1Dloop mutant that stabilizes cytosolic b-catenin, leading to enhanced b-catenin/LEF signaling , was unable to reduce Fbw7a, it is possible that b-catenin signaling may be involved in Fbw7 upregulation. To our knowledge, this is the first study showing a molecular mechanism regulating Fbw7 expression at the transcriptional level. We show for the first time a possible crosstalk between Fbw7 and EGFR during cell growth and transformation. Several observations show that Fbw7 positively modulates EGFR stability and signaling, and that this effect is isoform-and E3 ligase activity-dependent. First, Fbw7a increased EGFR stability and signaling, whereas Fbw7b, the loss of function mutants lacking the F-box domain or the dominant mutant dnFbw7 WD did not affect or reduced EGFR stability ( Figure 5 and not shown). Second, EGFR was downregulated by genetic inactivation of Fbw7 in embryonic fibroblasts and 
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V Rocher-Ros et al epithelial cells or after expression of PS1, which decreased Fbw7, in PSÀ/À fibroblasts ( Figures 5 and 7) . Finally, Fbw7 silencing reduced abnormal EGFRdependent anchorage-independent growth of PS-deficient fibroblasts. These findings define a new role for Fbw7 on facilitating EGFR stability and signaling in epidermal cells, but they do not clarify whether Fbw7 affects EGFR degradation directly or indirectly through an unknown effector (Figure 7e ). These results contrast with the established function of Fbw7 as a tumor suppressor gene in several malignancies including epithelial tumors (Perez-Losada et al., 2005; Welcker and Clurman, 2008) . Alternatively, our results indicate a crosstalk between PS and EGFR through Fbw7 on malignant transformation and skin carcinogenesis. It is well-established that EGFR signaling promotes keratinocyte growth and transformation (Kalyankrishna and Grandis, 2006) . The analysis of ePS cDKO mice allowed us to show a reciprocal regulation between EGFR and Fbw7 during progression of neoplastic epidermal hyperplasia. The enhancement of EGFRmediated cell proliferation and transformation caused by loss of PS strongly argues for a role of abnormal EGFR signaling in PS-dependent epidermal hyperplasia. Although our results agree with recent reports showing elevated EGFR levels in skin tumors of PS1-and nicastrin-deficient mice (Li et al., 2007; Repetto et al., 2007; Zhang et al., 2007) , they also provide a novel mechanism of EGFR regulation. Loss of PS affected EGFR recycling and degradation, whereas EGF-induced EGFR internalization was unaffected. Efficient lysosomal sorting and degradation of EGFR, but not internalization, require ubiquitination and proteasome-dependent deubiquitination (Longva et al., 2002; Alwan et al., 2003) , although sustained multiubiquitination regulates receptor trafficking and degradation (Mosesson et al., 2003; Huang et al., 2006) . The fact that loss of PS enhances basal ubiquitination and accelerates multi-deubiquitination of EGFR, which alters its proteasome-dependent downregulation, argues for a role of PS in regulating an ubiquitination/ deubiquitination step essential for trafficking of EGFR during the late endosomal/lysosomal pathway (Repetto et al., 2007) (Supplementary Figure S2) . It is possible that non-proteolytic functions of ubiquitin, as those related with cell signaling or trafficking (Chen and Sun, 2009) , may also contribute to altered EGFR trafficking and degradation.
Our results also raise the possibility that abnormal EGFR signaling in concert with stabilization of bcatenin levels (Xia et al., 2001; Tournoy et al., 2004 ) may contribute to tumor formation in PS-deficient mice. Deletion of the b-catenin binding domain in PS1 prevents skin tumors (Deng et al., 2006) , whereas inactivation of Notch1 signaling causes skin tumors (Nicolas et al., 2003; Proweller et al., 2006) , suggesting that altered EGFR and Notch signaling may participate in the oncogenic phenotype caused by PS deficiency. Indeed, an antagonistic crosstalk between the let-23/ EGFR and lin-12/Notch signaling pathways occurs during vulval precursor cell patterning in C. elegans Fbw7-dependent regulation of EGFR signaling V Rocher-Ros et al (Shaye and Greenwald, 2002) . Notably, LRBA, a sel-2 homolog that negatively regulates lin-12/Notch, promotes growth of cancer cells by regulating EGFR trafficking and signaling (Wang et al., 2004; de Souza et al., 2007) . In proliferating keratinocytes and SCC, EGFR signaling was recently shown to suppress Notch signaling by negatively regulating Notch1 expression through p53 (Kolev et al., 2008) . In agreement with a PS-dependent crosstalk between EGFR and Notch1 during epidermal carcinogenesis, reduced PS1 levels were recently associated with deficient Notch1 cleavage and elevated EGFR levels in skin papillomas of activating transcription factor-2 conditional knockout mice (Bhoumik et al., 2008) . This scenario contrasts with the stabilization of NICD caused by Fbw7 mutations in leukemia (O'Neil et al., 2007) . Besides regulating positively Notch signaling by generating the g-secretase-derived NICD (De Strooper et al., 1999) , our study shows that PS delays NICD degradation by controlling Fbw7 levels. Consistently, we found reduced NICD together with enhanced Fbw7 levels in keratinocytes from ePS cDKO mice. Nonetheless, Notch1 activation in epidermal basal keratinocytes triggers premature differentiation and reduced proliferation (Blanpain et al., 2006) , whereas loss of Notch function causes deficient epidermal differentiation and tumorigenesis (Nicolas et al., 2003; Proweller et al., 2006) . Future studies will be necessary to discern the specific mechanisms regulating the crosstalk of b-catenin, Notch and EGFR signaling during epidermal transformation. In light of these findings, we propose a role of PS in regulating the crosstalk between EGFR and Notch signaling through Fbw7 during skin carcinogenesis.
Materials and methods
Plasmids and antibodies
The FlagdnFbw7 WD , HA-Fbw7a and pCS2 mNICD-Myc plasmids were previously described (Kopan et al., 1996; Welcker et al., 2004) . The pER1-Luc plasmid contains the EGFR promoter cloned into the HindIII site of pGL3-Basic (Promega, Madison, WI, USA) (Rikiyama et al., 2003) . Human PS1 Generation of epidermal-specific PS cDKO mice We generated PS2-null mice in which PS1 was conditionally ablated in epidermal keratinocytes by crossing homozygous floxed PS1 (f/f); PS2À/À mice (Saura et al., 2004) to K14-Cre-ER T2 transgenic mice (Li et al., 2000) . PS1 f/ þ ; PS2 þ /À K14-Cre-ER T2 mice were backcrossed to PS1 f/f; PS2À/À mice to obtain PS1 f/f; PS2 þ /À (control) and PS1 f/f; PS2À/À K14-Cre-ER T2 mice. The PS1 f/f and PS2À/À mice were generated in C57BL6/129 hybrid background, whereas K14-Cre-ER T2 mice were of a C57BL/6 background. The Cre-ER T2 transgene was detected in genomic DNA tails and dorsal skins by PCR using the following primers P156, 5 0 -GCCTGCATTACCGG TCGATGCAACGA-3 0 and P157, 5 0 -GTGGCAGATGGCGC GGC AACACCATT-3 0 . Primary keratinocytes from 2-to 3-day-old littermate PS1 f/f; PS2 þ /À (control) and PS1 f/f; PS2À/À; K14-Cre-ER T2 pups were cultured and differentiated for 1-week as previously described (Pirrone et al., 2005) . For efficient recombination, 4-hidroxy-tamoxifen (Sigma-Aldrich) dissolved in acetone or ethanol was applied to skin (2 mg) or cultured keratinocytes (200 nM) for 72 h. All animal procedures were conducted in accordance with European Union guidelines on animal welfare and approved by the Institutional Ethical Committee.
Cell lines and proliferation assays
Mouse embryonic fibroblasts derived from control, PSÀ/À or Fbw7 f/f mouse embryos and the epithelial C5N cell lines have been previously described (De Strooper et al., 1999; Mao et al., 2004) . For Fbw7 silencing, a Fbw7 small interfering RNA targeting coding region 1965-1983 of exon 10 was cloned into pSuper retrovirus vector (OligoEngine, Seattle, WA, USA) (Mao et al., 2004) . After retroviral infection, cells were selected with puromycin (3 mg/ml) for 7 days. To generate stable cell pools, PS1/PS2 and PSÀ/À MEFs were transfected with pAG3Zeo, pAG3Zeo-PS1 or pAG3Zeo-PS1Dloop by using LipofectAMINE 2000 (Invitrogen, Carlsbad, CA, USA) and selected with zeocin (0.4 mg/ml) for 14 days (Saura et al., 2000) . For proliferation assays, cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 0.1-10% fetal bovine serum and treated with vehicle or the indicated inhibitors. Anchorage-independent cell growth assay was performed by culturing 5000 cells resuspended in DMEM/0.35% agar/10% fetal bovine serum containing vehicle or PD168393 (2 mM; 4 h) onto a layer of 0.5% agar for 15 days (Di Fiore et al., 1987) . Experiments were performed in triplicate.
Biochemical analyses
For signaling assays, cells were serum-starved for 3 h and incubated with serum-deprived DMEM containing EGF (50-150 ng/ml) (R&D Systems, Minneapolis, MN, USA) at 37 1C for the indicated times. Cells were lysed with RIPA-DOC buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2,5 mM EDTA, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM Na 3 VO 4 , 50mM NaF, 1 mM phenylmethylsulfonyl fluoride) supplemented with protease and phosphatase inhibitors (Sigma-Aldrich). EGFR turnover was analyzed in MEF in the presence or absence of EGF (150 ng/ml) and/or cycloheximide (25 mg/ml) plus NH 4 Cl (10 mM) or lactacystin (50 mM). EGFR stability was assayed in 293T cells transiently transfected with the indicated Fbw7 plasmids. Ubiquitination assays were performed in serum-starved cells incubated with vehicle or EGF (150 ng/ml) in DMEM for 15 min at 4 1C. Cells were washed, chased in DMEM at 37 1C for 0-30 min and lysed in RIPA-DOC buffer. Protein lysates (1 mg) were precipitated with P4D1 antibody or immunoglobulin-G plus protein A-sepharose. Immunoblotting was performed on 7.5-12.5% SDS-polyacrylamide gel electrophoresis as previously described (Saura et al., 2000) .
Immunohistological and immunofluorescence analyses
Deparaffinized mouse dorsal skins sections (5-10 mm) were stained with hematoxylin and eosin or peroxide inactivated and/or pretreated with antigen retrieval citrate (Biogenex, San Ramon, CA, USA). Sections were stained with antibodies against PS1 NT (1:100) or EGFR (1:250) and processed for avidin-biotin immunoperoxidase by using the Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA, USA). For immunofluorescence staining, sections were pretreated with antigen retrieval citrate, stained with anti-Fbw7 antibody (1:250), anti-rabbit Alexa Fluor 594 antibody (1:300; Invitrogen) and Hoechst (1:10 000) as previously described (Saura et al., 2004) . For Fbw7 and EGFR immunostaining, cells were permeabilized (0.1% saponin in phosphate-buffered saline), blocked and incubated with rabbit anti-Fbw7 (1:100) and mouse aEGFR (1:200; clone 225) plus anti-mouse biotinylated (1:100) antibodies before incubation with streptavidin-Cy3 (1:400) and anti-rabbit Alexa Fluor488 (1:400) and Hoechst. EGFR internalization was analyzed by incubating cells with EGF-Alexa488 (150 ng/ml; Invitrogen) at 4 1C for 15 min to avoid internalization (time 0) and chased for 15-180 min at 37 1C. Images were obtained using a Leica TCS SP5 AOBS confocal microscope and analyzed with MetaMorph 6.1 software (Universal Imaging, West Chester, PA, USA). For colocalization analysis, the number of double pixels for EGFR/Fbw7 relative to total EGFR pixels was counted for each cell field (7-8 cells per field) by using ImageJ 1.43k.
Quantitative real-time reverse transcription-PCR assays Total RNA was isolated using the RNAeasy mini kit (Qiagen, Valencia, CA, USA) and reverse transcribed using the SuperScript II Reverse Transcriptase kit (Invitrogen). Quantitative reverse transcription-PCR was performed with specific primers and the QuantiMix EASY SYG kit (Biotools, Madrid, Spain) in an ABI PRISM 7900 Sequence Detector (Applied Biosystems, Foster City, CA, USA). Values were normalized to glyceraldehyde-3-phosphate dehydrogenase. Data analysis was performed by the DDC t method using the SDS software v.2.1.
Statistical analysis
Statistical analysis was performed using the two-tailed Student's t-test or one-way analysis of variance (Super-ANOVA program). Comparisons among multiple groups were examined by Scheffe´'s S post hoc test. Data represent the mean ± s.d. or s.e.m. Differences with Po0.05 were considered to be significant.
